Company Overview of Plandaí Biotechnology, Inc.
Plandaí Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. It is developing two extracts, including Phytofare Catechin Complex, which is derived from green tea harvested in the Senteeko Tea Estate in Mpumalanga, South Africa; and Phytofare Limonoid Glycoside Complex extracted from lemons that are sourced from plantations in South Africa. The company also produces and sells timber and agricultural products from its farm and tea estate holdings in South Africa. In addition, it intends to use its plantation leases to focus on the farming of whole fruits, vegetables, and live plant material. The company is based in...
1451 North 200 East
Logan, UT 98102
Key Executives for Plandaí Biotechnology, Inc.
Co-Founder, Chairman, Chief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer and Secretary
Total Annual Compensation: $117.5K
Vice President of Sales and Director
Total Annual Compensation: $95.0K
Vice President of Marketing and Director
Total Annual Compensation: $9.0K
Compensation as of Fiscal Year 2014.
Plandaí Biotechnology, Inc. Key Developments
Plandai Biotechnology Inks Pact to Supply Phytofare to ProTec Nutra
Jul 3 15
Plandai Biotechnology announced that it has entered into an agreement with ProTec Nutra to become the official distributor of the company's Phytofare Catechin Complex in the United Kingdom. ProTec has placed its first order for Plandai's Phytofare Catechin Complex to fill confirmed orders that ProTec has received from its client base in the UK. ProTec sources, develops and markets specialty ingredients and bulk products into the Functional Foods and Nutraceuticals markets in Europe with a number of manufacturing partners including Plandai Biotechnology.
Plandaí Biotechnology, Inc. Appoints Jessica Snyder-Gutierrez as Executive Vice President and Secretary
Jun 10 15
Effective June 8, 2015, Jessica Snyder-Gutierrez was appointed Plandaí Biotechnology, Inc.'s Executive Vice President and Secretary for a term of three years. From 2011 to 2015, Ms. Snyder Gutierrez served as a Quality Analyst and Compliance Officer for J.P. Morgan Chase.
Plandaí Biotechnology, Inc. announced delayed 10-Q filing
May 15 15
On 05/15/2015, Plandaí Biotechnology, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries